Search results - 2 results
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
expert team in 2009, based on reproducibility and relative sensitivity and specificity compared to Hybrid Capture-2 or GP5 +/6+ PCR-enzyme immunoassay. These latter two hrHPV DNA assays were validated in ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types. LMNX is additionally provided ...